Carmen Berenguer | Behavioral Neuroscience | Women Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Carmen Berenguer | Behavioral Neuroscience | Women Researcher Award

Assoc. Prof. Dr. Carmen Berenguer | Universitat de Valencia | Spain

Dr. Carmen Berenguer is an Associate Professor in the Department of Developmental and Educational Psychology at the University of Valencia. She holds a degree in Psychology, a Master’s in Cognitive Neuroscience and Special Educational Needs, and a Ph.D. in Psychology with the distinction of Cum Laude and International Doctorate from the same university. Her research has consistently focused on neurodevelopmental disorders, particularly Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD), exploring cognitive, social, communication, and learning dimensions. In recent years, she has extended her work to examine comorbid conditions such as sleep difficulties and to design psychosocial intervention programs for families of children with ASD and ADHD. Dr. Berenguer has completed or participated in nine research projects and authored 20 books. She holds two patents related to psychosocial programs and augmented reality applications for educational and therapeutic purposes. With 54 published documents, her work has been cited in 994 scientific papers, accumulating a total of 1,077 citations and achieving an h-index of 17, reflecting her significant impact in developmental psychology and neurodevelopmental research.

Profiles: Scopus | orcid | Google Scholar

Featured Publications

(2025). Characteristics, motivations and attitudes of students using ChatGPT and other language model-based chatbots in higher education. Education and Information Technologies.

(2025). Parenting stress in autistic and ADHD children: Implications of social support and child characteristics. Journal of Autism and Developmental Disorders.

(2025). Sleep disturbances in autistic children and adolescents: A systematic review and meta-analysis of randomized controlled trials.

(2025). Augmented reality and learning-cognitive outcomes in autism spectrum disorder: A systematic review.

(2025). Occupational stress, burnout, and job satisfaction amongst Spanish speech-language pathologists. International Journal of Speech Language Pathology.

Danai Veltra | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Danai Veltra | Neurogenetics and Molecular Neuroscience | Best Researcher Award 

Dr. Danai Veltra | National and Kapodistrian University | Greece

Dr. Danai Veltra is a Greek medical researcher specializing in clinical genetics and genomic medicine, with a strong focus on rare genetic disorders, epileptic encephalopathies, and neurodevelopmental syndromes. Her research contributions encompass genetic diagnostics through Next Generation Sequencing (NGS) and Whole Exome Sequencing (WES), significantly improving the identification and understanding of Mendelian and chromosomal disorders. She has presented her work at numerous prestigious international conferences, including the European Human Genetics Conference and the European Paediatric Neurology Society Congress, where she has contributed to studies on Marfan syndrome, Williams syndrome, Melnick-Needles syndrome, and Diamond Blackfan Anemia. Dr. Veltra has co-authored impactful publications in leading journals such as the European Journal of Paediatric Neurology, Gynecological Endocrinology, and American Journal of Medical Genetics. Her collaborative work has enhanced genotype–phenotype correlations and advanced precision medicine approaches in pediatric and hereditary diseases. With 237 citations, an h-index of 7, and an i10-index of 5, she has established herself as a promising scientist in medical genetics, contributing both to clinical application and academic advancement in human genomics and molecular diagnostics.

Profile: Google Scholar

Featured Publications

Marinakis, N. M., Svingou, M., Veltra, D., Kekou, K., Sofocleous, C., Tilemis, F. N., … (2021). Phenotype‐driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders. American Journal of Medical Genetics Part A, 185(8), 2561–2571.

Zouvelou, V., Yubero, D., Apostolakopoulou, L., Kokkinou, E., Bilanakis, M., … Veltra, D. (2019). The genetic etiology in cerebral palsy mimics: The results from a Greek tertiary care center. European Journal of Paediatric Neurology, 23(3), 427–437.

Tilemis, F. N., Marinakis, N. M., Veltra, D., Svingou, M., Kekou, K., Mitrakos, A., … (2023). Germline CNV detection through whole-exome sequencing (WES) data analysis enhances resolution of rare genetic diseases. Genes, 14(7), 1490.

Pavinato, L., Delle Vedove, A., Carli, D., Ferrero, M., Carestiato, S., Howe, J. L., … (2023). CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD. Brain, 146(2), 534–548.

Saffari, A., Lau, T., Tajsharghi, H., Karimiani, E. G., Kariminejad, A., Efthymiou, S., … (2023). The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders. Brain, 146(8), 3273–3288.

Layo-Carris, D. E., Lubin, E. E., Sangree, A. K., Clark, K. J., Durham, E. L., … (2024). Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals. European Journal of Human Genetics, 32(8), 928–937.

Veltra, D., Kosma, K., Papavasiliou, A., Tilemis, F. N., Traeger‐Synodinos, J., … (2022). A novel pathogenic ATP6V1B2 variant: Widening the genotypic spectrum of the epileptic neurodevelopmental phenotype. American Journal of Medical Genetics Part A, 188(12), 3563–3566.

Maansi Solanky | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Maansi Solanky | Molecular and Cellular Neuroscience | Best Researcher Award

Ms. Maansi Solanky | LSU Health New Orleans | United States

Maansi Solanky is a dedicated medical scholar pursuing her Doctor of Medicine at LSU Health New Orleans, with a strong interdisciplinary background in health and human sciences from the University of Southern California. Her academic journey integrates medicine, analytics, and public health, reflected in her extensive research and operational experience across multiple institutions. As an Operations Analyst at Evergreen Nephrology, she contributed to improving healthcare delivery through data-driven solutions, process optimization, and interdepartmental collaboration. Her research at the USC Keck School of Medicine explored neural communication mechanisms underlying schizophrenia and analyzed food insecurity in Los Angeles County using advanced data analytics. Additionally, her work with the Louisiana Organ Procurement Agency led to actionable insights enhancing organ donation efficiency through comparative data modeling in R, SQL, and SAS. With teaching experience as a Chemistry Supplemental Instruction Leader for over 700 students, she demonstrates a passion for mentorship and education. Maansi is also deeply engaged in community initiatives promoting public health and equitable healthcare access. She has authored 5 research documents, accumulated 42 citations, and holds an H-index of 3, underscoring her growing influence in medical research and data-driven healthcare innovation.

Profile: Oricd

Featured Publication

Solanky, M., Khosla, M., & Alahari, S. K. (2025). Assessing the tumor suppressive impact and regulatory mechanisms of SPDEF expression in breast cancer. Cancers, 17(21), 3556.

William Blumentals | Clinical Neuroscience | Excellence in Research Award

Published on by Neuroscientists

Dr. William Blumentals | Clinical Neuroscience | Excellence in Research Award

Dr. William Blumentals | Sanofi | United States

Dr. William A. Blumentals is an accomplished epidemiologist and pharmaceutical executive recognized for his leadership in pharmacoepidemiology, real-world evidence generation, and global health outcomes research. He serves as Associate Vice President and Head of Specialty Care Pharmacoepidemiology at Sanofi in Cambridge, Massachusetts, where he oversees a multinational team of epidemiologists across the United States and Europe, driving innovation in inflammation, immunology, oncology, and rare disease research. With a Ph.D. in Epidemiology from the University of South Florida, along with advanced degrees in Statistics, Epidemiology, and Biology, Dr. Blumentals has held senior positions at leading organizations including Shire Pharmaceuticals, Shionogi Inc., and Hoffmann-La Roche. His expertise spans strategic development of large-scale observational studies, organizational leadership, and cross-functional collaboration to optimize evidence-based decision-making in healthcare. As a thought leader in real-world evidence and outcomes research, he has contributed significantly to advancing global epidemiological practices. Dr. Blumentals has authored 36 scientific documents, accumulated 1,594 citations from 1,463 documents, and holds an h-index of 23, reflecting his strong scientific influence and impact in epidemiology and pharmaceutical research.

Profile: Scopus

Featured Publications

Multiple sclerosis and the association with inflammatory bowel disease: Results from a retrospective cohort study. (2025). Multiple Sclerosis and Related Disorders.


Cytokine release syndrome risk model with T-cell engaging therapies. (2025). Cytotherapy.


Evaluating the accuracy of responses by large language models for information on disease epidemiology. (2025). Pharmacoepidemiology and Drug Safety.

Zhou Nan | Epilepsy | Best Researcher Award

Published on by Neuroscientists

Dr. Zhou Nan | Epilepsy | Best Researcher Award

Huashan Hospital Affiliated to Fudan University | China 

Dr. Zhou Nan is an attending physician in the department of neurosurgery at Huashan Hospital Affiliated to Fudan University. After completing his bachelor’s degree in clinical medicine at Second Military Medical University followed by a combined master’s and doctoral program in neurosurgery at Fudan University under the mentorship of Prof. Mao Ying, he spent time as a visiting scholar at the Brain Bank of the Netherlands Royal Academy of Arts and Sciences Institute of Neuroscience. Upon returning, he joined Huashan Hospital as a resident physician and later advanced to the role of attending physician. His research focuses on surgical treatment of refractory temporal lobe epilepsy, computational modelling of hippocampal circuits, and mesoscale stereotaxic 3D atlases of the mammalian brain, supported by major talent-program and national foundation grants. According to his Google Scholar profile, he has an h-index of [please insert current value] with [please insert document count] publications and [please insert citation count] citations. His work has strengthened the bridge between precision neurosurgery and brain-circuit modelling, earned him recognition in the Chinese and international neurosurgical research community, and positions him as a rising leader whose legacy promises further advances in interventions for drug-resistant epilepsy and neuro-circuit based atlases.

Profile: Scopus 

Featured Publications

Li, J., Cui, Z., Gong, H., Zhang, Y., Yuan, Z., Zhang, Z., Ma, Z., Zhou, N., Huang, C., Zhao, Y., Li, X., Zhang, Z., & Sun, Y. (2025). Sleep deficiency exacerbates periodontal inflammation via trigeminal TRPV1 neurons. Proceedings of the National Academy of Sciences of the United States of America, 122 (24), e2424169122.

Zhiping Guo | Molecular and Cellular Neuroscience | Innovative Research Award

Published on by Neuroscientists

Dr. Zhiping Guo | Molecular and Cellular Neuroscience | Innovative Research Award

Dr. Zhiping Guo | Taiyuan Central Hospital, Peking University First Hospital Taiyuan Branch | China

Dr. Zhiping Guo, an esteemed Associate Chief Physician and Department Head at the Department of Hematology, Peking University First Hospital Taiyuan Branch (Taiyuan Central Hospital), is widely recognized for his dedicated contributions to the field of hematology. Having completed his postdoctoral research at the Peking University Institute of Hematology under the mentorship of Professor Xiaojun Huang, Dr. Guo has focused extensively on the diagnosis and treatment of hematological diseases, with remarkable advancements in clinical research and therapeutic strategies. He has successfully led multiple grant-funded research projects supported by prestigious provincial and municipal foundations. Dr. Guo has published over twenty peer-reviewed scientific papers in reputed international journals indexed in SCI and Scopus, reflecting his strong research output. His scholarly influence is underscored by an impressive h-index of 12, with more than 480 citations and 28 documented research works available in leading academic databases. As a peer reviewer for several international journals such as Molecular Medicine Reports, International Journal of Molecular Medicine, Experimental and Therapeutic Medicine, World Academy of Sciences Journal, and Oncology Letters, Dr. Guo plays a vital role in advancing global hematology research. A committed member of the EBMT, he continues to integrate innovation, clinical excellence, and academic leadership in his pursuit of improving hematological healthcare.

Profile: Orcid 

Featured Publications 

Zhao, L., Zhang, Y., Guo, X., Li, Z., Lu, W., Pan, Z., Guo, Y., Sun, J., Zhang, Y., Hao, J., et al. (2024). Peripheral blood lymphocyte subsets in factor VIII inhibitor-positive patients with severe hemophilia A: A case-control study. Clinical and Applied Thrombosis/Hemostasis, 30(1).

Guo, Z., Chen, X., Tan, Y., Xu, Z., & Xu, L. (2020). Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study. Blood Cells, Molecules, and Diseases, 81, 102393.

Guo, Z.-P., Tan, Y.-H., Li, J.-L., Xu, Z.-F., Chen, X.-H., & Xu, L.-R. (2018). Acute pro-B-cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review. Oncology Letters, 15(5), 6895–6901.

Zhu, H.-H., Guo, Z.-P., Jia, J.-S., Jiang, Q., Jiang, H., & Huang, X.-J. (2018). The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia. Leukemia Research, 66, 75–80.

 Guo, Z., Yang, L., Qin, X., Liu, X., & Zhang, Y. (2018). Spectrum of molecular defects in 216 Chinese families with hemophilia A: Identification of noninversion mutation hot spots and 42 novel mutations. Clinical and Applied Thrombosis/Hemostasis, 24(1), 134–141.

Kushal J | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Kushal J | Clinical Neuroscience | Best Researcher Award

Mr. Kushal J |  Acharya and B M Reddy College of Pharmacy | India

Kushal J’s research focuses on pharmaceutical analysis, drug formulation, and healthcare innovation, reflecting a deep interest in bridging traditional and modern approaches to drug development. His work includes the formulation, development, and evaluation of an anti-acne serum using cow’s urine, a study that explores bioactive natural resources for dermatological applications. He has also contributed to analytical chemistry through his project on analytical method development and validation for identifying selected genotoxic impurities in bulk and pharmaceutical dosage forms by the RP-HPLC DAD method, presented at the JSS Pharmanecia International Research Conference. His academic training emphasizes analytical instrumentation, including HPLC, UV-Vis spectrophotometry, and dissolution testing, supported by a strong understanding of Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has further strengthened his theoretical foundation through certifications in Food Chemistry and Biomedical Research. Kushal’s growing research portfolio highlights his dedication to advancing pharmaceutical quality control, regulatory compliance, and innovation in formulation science. His goal is to apply analytical and formulation expertise toward developing safer, more effective, and sustainable pharmaceutical products, contributing to the evolving fields of pharmaceutical technology, analytical method development, and health informatics.

Profile: Orcid

Featured Publication

Kushal, J., Loganathan, C. G., Rajesh, R., Dutta, S., Paik, A., Dasgupta, A., Reddy, G. N. N., & Suchindar, A. (2025). Recent advances in quinoline derivatives: Biological and medicinal insights. ChemistrySelect.

Calixto Machado | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Calixto Machado | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Calixto Machado | Institute of Neurology and Neurosurgery | Cuba

Calixto Machado is a Full Professor and Senior Researcher in Neurology and Clinical Neurophysiology at the Institute of Neurology and Neurosurgery in Havana, Cuba, and a Corresponding Fellow of the American Academy of Neurology. He completed his medical degree, followed by specialist training in neurology and clinical neurophysiology, and then earned his PhD. Over four decades he has led pioneering research on disorders of consciousness, brain death, stroke, autism, autonomic nervous system disorders and the neurological sequelae of SARS-CoV-2. He has published nearly 700 peer-reviewed journal articles, book chapters and authored seven books; his work is recognised internationally through numerous symposia and awards. His Google Scholar profile lists an h-index of 37, and over 24 000 citations across his published documents.

Profile: Google Scholar

Featured Publications:

Machado, C. (2025, September 9). Jahi McMath case: A comprehensive and updated narrative. World Journal of Critical Care Medicine, 14(3), 107513.

Machado, C. (2022). The Jahi McMath case: First detailed study of her brain. Neurology India, 70(5), 22–35.

Giacino, J. T., Ashwal, S., Childs, N., Cranford, R., Jennett, B., Katz, D. I., Kelly, J. P., & others. (2002). The minimally conscious state: Definition and diagnostic criteria. Neurology, 58(3), 349–353.

Sloan, M. A., Alexandrov, A. V., Tegeler, C. H., Spencer, M. P., Caplan, L. R., & others. (2004). Assessment: Transcranial Doppler ultrasonography report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 62(9), 1468–1481.

Machado, C. (2002). Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria. Neurology.

Machado, C. (2007). Cerebral response to patient’s own name in the vegetative and minimally conscious states. Neurology, 69(7), 708.

Machado, C., Korein, J., Ferrer, Y., Portela, L., & others. (2007). The concept of brain death did not evolve to benefit organ transplants. Journal of Medical Ethics, 33, 197–200.

Machado, C. (2007). The concept of brain death did not evolve to benefit organ transplants. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2007). Brain death: A reappraisal. Springer Science & Business Media.

Machado, C. (2007). The first organ transplant from a brain-dead donor. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2010). Diagnosis of brain death. Neurology International, 2(1), e2.

Graf, W. D., Miller, G., Epstein, L. G., & Rapin, I. (2017). The autism “epidemic”: Ethical, legal, and social issues in a developmental spectrum disorder. Neurology, 88(14), 1371–1380.

Machado, C., Korein, J., Aubert, E., Bosch, J., Alvarez, M. A., Rodríguez, R., & others. (2007). Recognizing a mother’s voice in the persistent vegetative state. Clinical EEG and Neuroscience, 38(3), 124–126.

Lewis, A., Bernat, J. L., Blosser, S., Bonnie, R. J., Epstein, L. G., Hutchins, J., & others. (2018). An interdisciplinary response to contemporary concerns about brain death determination. Neurology, 90(9), 423–426.*

Rene Pry | Neurodevelopmental Processes | Best Researcher Award

Published on by Neuroscientists

Mr. Rene Pry | Neurodevelopmental Processes | Best Researcher Award

Mr. Rene Pry | Universite Montpellier3-Paul Valery | France

René Pry is a distinguished scholar and researcher affiliated with Université Paul-Valéry Montpellier 3 in France, specializing in clinical psychology and developmental psychopathology. His academic work primarily explores neurodevelopmental disorders, particularly autism spectrum disorders (ASD), from a developmental and evolutionary psychopathology perspective. Pry’s research focuses on understanding the psychological, cognitive, and emotional processes that underlie atypical development, emphasizing how early life experiences and environmental factors shape mental health trajectories. He has contributed extensively to the field through numerous publications addressing autism, childhood mental health, and the clinical approaches used in diagnosis and intervention. As an influential figure in French psychological research, Pry has played a significant role in bridging theoretical models with clinical practice, offering insights into both the scientific and therapeutic dimensions of neurodevelopmental conditions. His recent works, such as those published in Annales Médico-Psychologiques and Neuropsy, highlight his continued commitment to advancing knowledge on the complex interplay between neurobiology, development, and psychopathology. Through his research and teaching, René Pry has established himself as a leading voice in the study of autism and developmental psychology, fostering a nuanced understanding of mental health across the lifespan.

Profile: Orcid

Featured Publications

Pry, R., & El Achhab, A. (2025). Troubles neurodéveloppementaux et psychopathologie évolutionniste. L’autisme en situation. Annales Médico-psychologiques, revue psychiatrique.

Pry, R., & El Achhab, A. (2025). « L’autisme profond » : une casuistique pour le clinicien. Neuropsychiatrie de l’Enfance et de l’Adolescence.

Achachera, A., & Pry, R. (2025). L’inclusion scolaire des enfants autistes en Algérie. Journal of Science and Knowledge Horizons.

Nobuhiro Inoue | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Nobuhiro Inoue | Neuropharmacology | Best Researcher Award

Dr. Nobuhiro Inoue | Kumamoto Neurosurgical Hospital | Japan

Dr. Nobuhiro Inoue is a distinguished neurosurgeon affiliated with Kumamoto Neurosurgical Hospital in Japan, recognized for his extensive contributions to the field of neurosurgery and neurological research. His clinical expertise encompasses advanced microsurgical techniques, neurotrauma management, cerebrovascular disorders, and brain tumor surgery. Dr. Inoue has published numerous scientific papers in reputable international journals, reflecting his commitment to advancing medical knowledge and improving neurosurgical outcomes. His research often focuses on the pathophysiology of brain and spinal diseases, the development of minimally invasive surgical methods, and innovative neuroimaging applications in clinical practice. As an active contributor to academic and clinical advancements, Dr. Inoue collaborates with interdisciplinary teams to integrate cutting-edge technology and evidence-based approaches in patient care. His scientific works have been widely cited, underscoring their influence on neurosurgical research and education. Through his dedication to both surgery and scientific inquiry, Dr. Nobuhiro Inoue continues to play a vital role in enhancing the understanding and treatment of complex neurological conditions in Japan and beyond.

Profile: Orcid

Featured Publications

Inoue, N., & Goto, S. (2025). Clinical evidence of senile choreo-athetosis following valproate withdrawal: A case report. Neurology and Clinical Neuroscience.

Inoue, N. (2020). Post-stroke dizziness of visual vestibular cortices origin. Journal of Neuroscience and Neurological Disorders.

Inoue, N. (2017). Severe ischemic stroke due to progression of cervical carotid artery dissection. Neurological Research and Therapy, 17(22).

Inoue, N. (2015). Cerebral blood flow in the visual and parieto-insular vestibular cortices in patients after cerebral ischemia with or without dizziness. International Journal of Neurological Disorders & Interventions, 101.

Inoue, N. (2014). Effect of ibudilast on the reciprocal inhibitory visual-vestibular interaction closely related to dizziness after cerebral ischemia. Journal of Stroke and Cerebrovascular Diseases, 23, 51–55.

Inoue, N. (2011). Highly purified eicosapentaenoic acid improves cerebral vasomotor-reactivity in patients with chronic cerebral ischemia. Therapeutic Research, 32, 1325–1332.

Inoue, N. (2010). Long-term suppression of Meige syndrome after pallidal stimulation: A 10-year follow-up study. Movement Disorders, 25(11), 1753–1763.

Inoue, N. (2009). Relationship between dizziness and cerebral blood flow in patients with chronic cerebral ischemia. In A. Lindqvist & G. Nyman (Eds.), Dizziness: Vertigo, disequilibrium and lightheadedness. Nova Science Publishers. ISBN 978-1-60741-847-4